SEC FORM 4
$44,324.94
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Sale of 9,273 shares at $4.78 per share.
Reporting Person Reynoso Jamie L. · Officer Title CEO, Medicare Advantage · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001839066-26-000045 · filed 2026-09-15 · View filing →